Suppr超能文献

帕金森病与癫痫共同特征的叙述性综述

Narrative Review on Common Traits of Parkinson's Disease and Epilepsy.

作者信息

Tilz Christian, Wang-Tilz Ying

机构信息

Epilepsy Center Bodensee, Clinik of Neurology and Epileptology, ZfP Südwürttemberg, Weingartshofer Str. 2, 88214 Ravensburg, Germany.

Department of Neurology, University Hospital of Graz, Univesity Graz, Auenbruggerplatz 22, 8036 Graz, Austria.

出版信息

J Clin Med. 2025 Apr 15;14(8):2716. doi: 10.3390/jcm14082716.

Abstract

Epilepsy and Parkinson's disease (PD) are two common neurological disorders, with a lifetime prevalence of approximately 1% and 0.4%, respectively. Both conditions affect movement and brain function and were traditionally considered distinct, with different pathophysiological mechanisms. However, recent research suggests potential links between them. Some studies indicate that epilepsy may contribute to the development of PD due to chronic neuroinflammation, excitotoxicity, and neuronal loss. Conversely, PD-related neurodegeneration in dopaminergic pathways might increase susceptibility to seizures. This article presents a narrative review of the limited literature on the pathophysiological mechanisms linking epilepsy and PD, including shared genetic factors, neurodegenerative processes, and alterations in the neurotransmitter system. It also examines the influence of anti-seizure medications and dopaminergic treatments on the symptoms and progression of both disorders, as well as their common clinical features. Additionally, the limitations of the existing data on this topic are discussed. Understanding the true relationship between these two disorders is crucial, as it could provide insight into common neurobiological mechanisms and lead to improved therapeutic strategies.

摘要

癫痫和帕金森病(PD)是两种常见的神经系统疾病,终生患病率分别约为1%和0.4%。这两种疾病都会影响运动和脑功能,传统上被认为是不同的,具有不同的病理生理机制。然而,最近的研究表明它们之间存在潜在联系。一些研究表明,由于慢性神经炎症、兴奋性毒性和神经元丢失,癫痫可能导致PD的发生。相反,多巴胺能通路中与PD相关的神经退行性变可能会增加癫痫发作的易感性。本文对关于癫痫和PD之间病理生理机制的有限文献进行了叙述性综述,包括共同的遗传因素、神经退行性变过程以及神经递质系统的改变。它还研究了抗癫痫药物和多巴胺能治疗对这两种疾病症状和进展的影响,以及它们的共同临床特征。此外,还讨论了关于该主题现有数据的局限性。了解这两种疾病之间的真正关系至关重要,因为它可以深入了解共同的神经生物学机制,并带来改进的治疗策略。

相似文献

1
Narrative Review on Common Traits of Parkinson's Disease and Epilepsy.
J Clin Med. 2025 Apr 15;14(8):2716. doi: 10.3390/jcm14082716.
2
Advances in NURR1-Regulated Neuroinflammation Associated with Parkinson's Disease.
Int J Mol Sci. 2022 Dec 19;23(24):16184. doi: 10.3390/ijms232416184.
3
Parkinson's Disease, Diabetes and Cognitive Impairment.
Recent Pat Endocr Metab Immune Drug Discov. 2016;10(1):11-21. doi: 10.2174/1872214810999160628105549.
4
Association Between Bipolar Disorder and Parkinson's Disease.
Psychiatr Danub. 2023 Oct;35(Suppl 2):66-71.
5
A possible pathway to freezing of gait in Parkinson's disease.
J Parkinsons Dis. 2025 Mar;15(2):282-290. doi: 10.1177/1877718X241308487. Epub 2025 Jan 14.
6
SynNeurGe: The road ahead for a biological definition of Parkinson's disease.
J Parkinsons Dis. 2024 Dec 8:1877718X241298194. doi: 10.1177/1877718X241298194.
9
Trib3 Is Elevated in Parkinson's Disease and Mediates Death in Parkinson's Disease Models.
J Neurosci. 2015 Jul 29;35(30):10731-49. doi: 10.1523/JNEUROSCI.0614-15.2015.
10
Nuclear Factor Kappa B: A Nobel Therapeutic Target of FlavonoidsAgainst Parkinson's Disease.
Comb Chem High Throughput Screen. 2024;27(14):2062-2077. doi: 10.2174/0113862073295568240105025006.

本文引用的文献

2
New epilepsy therapies in development.
Nat Rev Drug Discov. 2024 Sep;23(9):682-708. doi: 10.1038/s41573-024-00981-w. Epub 2024 Jul 22.
3
Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2024 Update.
J Parkinsons Dis. 2024;14(5):899-912. doi: 10.3233/JPD-240272.
4
A Mutual Nexus Between Epilepsy and α-Synuclein: A Puzzle Pathway.
Mol Neurobiol. 2024 Dec;61(12):10198-10215. doi: 10.1007/s12035-024-04204-6. Epub 2024 May 4.
6
Increasing incidence of Parkinson's disease in patients with epilepsy: A Nationwide cohort study.
J Neurol Sci. 2024 Mar 15;458:122891. doi: 10.1016/j.jns.2024.122891. Epub 2024 Jan 24.
7
A biological classification of Parkinson's disease: the SynNeurGe research diagnostic criteria.
Lancet Neurol. 2024 Feb;23(2):191-204. doi: 10.1016/S1474-4422(23)00404-0.
8
A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research.
Lancet Neurol. 2024 Feb;23(2):178-190. doi: 10.1016/S1474-4422(23)00405-2.
9
Voltage-Gated Sodium Channel Dysfunctions in Neurological Disorders.
Life (Basel). 2023 May 16;13(5):1191. doi: 10.3390/life13051191.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验